On the other hand, Bcl-2 as an antiapoptotic molecule protects tumour cells from induced apoptosis and may render RCC resistant to all kinds of apoptotic–triggering therapeutics, including chemotherapy and irradiation. Here, BCL2 is linked to renal cell carcinoma.